Chlorthalidone versus hydrochlorothiazide for preventing cardiovascular disease in hypertension: Is the case closed?

Ernst, 2022, Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide, Am J Hypertens, 35, 573, 10.1093/ajh/hpac048 Agarwal, 2022, Hydrochlorothiazide Versus Chlorthalidone: What Is the Difference?, Circulation, 146, 1641, 10.1161/CIRCULATIONAHA.122.061029 Williams, 2018, 2018 ESC/ESH Guidelines for the management of arterial hypertension, Eur Heart J, 39, 3021, 10.1093/eurheartj/ehy339 Laffin, 2023, Newer alternatives for resistant hypertension: Beyond 2022 paradigms, Hellenic J Cardiol, 70, 75, 10.1016/j.hjc.2023.01.006 Roush, 2021, Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects, J Hypertens, 39, 1254, 10.1097/HJH.0000000000002771 Ishani, 2022, Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events, N Engl J Med, 387, 2401, 10.1056/NEJMoa2212270 Pareek, 2016, Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring, J Am Coll Cardiol, 67, 379, 10.1016/j.jacc.2015.10.083 Franse, 2000, Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program, Hypertension, 35, 1025, 10.1161/01.HYP.35.5.1025 Messerli, 2023, Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events, N Engl J Med, 388, 1341, 10.1056/NEJMc2301922 Ishani, 2023, Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply, N Engl J Med, 388, 1342 Agarwal, 2021, Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease, N Engl J Med, 385, 2507, 10.1056/NEJMoa2110730 Bandak, 2017, Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project, J Am Heart Assoc, 6, 10.1161/JAHA.116.005428